On World Alzheimer’s Day, we examine how a timely diagnosis can prepare someone with early dementia, and the pros and cons of ...

Recent research highlights the potential of microRNAs as cost-effective and less invasive biomarkers for early diagnosis and ...

A NEW blood test could detect Alzheimer’s disease in its early stages, years before symptoms begin to show. Tests that ...

The failure to diagnose Alzheimer's disease—the most common form of dementia in the elderly—at an early stage of molecular ...

There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...

Antidepressants have the potential to improve memory and thinking skills, a new study suggests. Some patients experienced a ...

For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...

Fear keeps some people awake at night. Their parents or grandparents had Alzheimer’s disease. Whenever they struggled to remember people’s names or forgot why they walked into a room, they worried if ...

A NEW blood test could detect Alzheimer's disease in its early stages, years before symptoms begin to show. Tests that evaluate specific molecules in the blood could pick up early signs of ...

Moreover, the researchers uncovered microRNA candidate molecular biomarkers that associate with current Amyloid, Tau, and Neurodegeneration (A/T/N) Alzheimer's biomarkers. The failure to diagnose ...

The study showed that serum miRNA signatures can be used as biomarkers for Alzheimer's disease and predict the transition ...